Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 10,000
- Avg volume
- 4,078
- Day's range
- $0.01 – $0.01
- Shares out
- —
- Stochastic %K
- 100%
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Allied Corp., a cannabis company, engages in the development, manufacture, and marketing of hemp derived cannabis products in the United States. It operates in two segments, Allied Colombia and Allied Corp. The company offers hemp-based CBD natural health products, as well as cannabis related products, including beauty and skincare products, and food and beverages. It also develops ALID 10 and ALID 11 for the treatme...
Show more
Allied Corp., a cannabis company, engages in the development, manufacture, and marketing of hemp derived cannabis products in the United States. It operates in two segments, Allied Colombia and Allied Corp. The company offers hemp-based CBD natural health products, as well as cannabis related products, including beauty and skincare products, and food and beverages. It also develops ALID 10 and ALID 11 for the treatment of post-traumatic stress disorder and related mental health conditions through the targeted function of the 5-HT2 receptor and physiological pathways. The company is headquartered in Kelowna, Canada.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 877-255-4337
- Website
- https://allied.health
- Address
- 200-460 Doyle Ave, Kelowna, Canada
Latest news
No headlines yet.
